Drug profile

The FDA adverse-event record for Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr

50 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr. See the species affected, top reactions, and outcomes below.

50
adverse-event reports
94.0%
death-coded share
Cattle
most-reported species
46
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
50
Total Reports
47
Deaths Reported
94.0%
Death Rate

Active Ingredients

Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr

Administration Routes

SubcutaneousUnknownNasal

Species Affected

Cattle 50

Most Affected Breeds

Mixed (Cattle) 47
Aberdeen Angus 2
Salers 1

Most Reported Reactions

Death 46
Lack of efficacy - NOS 40
Necropsy performed 19
Lack of efficacy (mycoplasma) - NOS 5
Lack of efficacy (bacteria) - Histophilus somni 4
Lack of efficacy (bacteria) - Mannheimia haemolytica 4
Lack of efficacy (virus) - bovine viral diarrhoea virus 4
Malaise 3
Pulmonary disorder NOS 3
Systemic disorder NOS 2
Intentional misuse 2
Musculoskeletal disorder NOS 2

Outcome Breakdown

Died
47 (54.0%)
Outcome Unknown
21 (24.1%)
Ongoing
16 (18.4%)
Recovered/Normal
3 (3.4%)

Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr Adverse Event Insights

50 reports name Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr; 47 recorded a death outcome (94.0% of reported events, not a population-level mortality rate). Active ingredient: Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr. Administration routes: Subcutaneous, Unknown, Nasal.

By species: Cattle (50 reports). By breed: Mixed (Cattle) (47), Aberdeen Angus (2), Salers (1).

Leading clinical signs: Death (46), Lack of efficacy - NOS (40), Necropsy performed (19), Lack of efficacy (mycoplasma) - NOS (5). Outcome, 87 coded reports: Died leads at 54.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.